Severe COVID-19-associated sepsis is different from classical sepsis induced by pulmonary infection with carbapenem-resistant klebsiella pneumonia (CrKP).
10.1016/j.cjtee.2021.11.001
- VernacularTitle:Severe COVID-19-associated sepsis is different from classical sepsis induced by pulmonary infection with
carbapenem-resistant klebsiella pneumonia (CrKP)
- Author:
Ming WU
1
;
Zhi-Ye ZOU
2
;
Yan-Hong CHEN
2
;
Cong-Lin WANG
3
;
Yong-Wen FENG
2
;
Zhi-Feng LIU
4
,
5
Author Information
1. Department of Critical Care Medicine and Hospital Infection Prevention and Control, Shenzhen Second People's Hospital, Shenzhen, 518035, China.
2. Department of Critical Care Medicine, First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China.
3. Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China.
4. Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou, 510010, China. Electronic address: zhifengliu7797@
5. com.
- Publication Type:Journal Article
- Keywords:
COVID-19;
Carbapenem-resistant klebsiella pneumonia (CrKP);
Clinical characteristics;
Immunosuppression;
Mortality
- MeSH:
COVID-19;
Carbapenems;
Hospital Mortality;
Humans;
Intensive Care Units;
Klebsiella;
Prognosis;
Retrospective Studies;
SARS-CoV-2;
Sepsis
- From:
Chinese Journal of Traumatology
2022;25(1):17-24
- CountryChina
- Language:English
-
Abstract:
PURPOSE:COVID-19 is also referred to as a typical viral septic pulmonary infection by 2019-nCoV. However, little is known regarding its characteristics in terms of systemic inflammation and organ injury, especially compared with classical bacterial sepsis. This article aims to investigate the clinical characteristics and prognosis between COVID-19-associated sepsis and classic bacterial-induced sepsis.
METHODS:In this retrospective cohort study, septic patients with COVID-19 in the intensive care unit (ICU) of a government-designed therapy center in Shenzhen, China between January 14, 2020 and March 10, 2020, and septic patients induced by carbapenem-resistant klebsiella pneumonia (CrKP) admitted to the ICU of the Second People's Hospital of Shenzhen, China between January 1, 2014 and October 30, 2019 were enrolled. Demographic and clinical parameters including comorbidities, critical illness scores, treatment, and laboratory data, as well as prognosis were compared between the two groups. Risk factors for mortality and survival rate were analyzed using multivariable logistic regression and survival curve, respectively.
RESULTS:A total of 107 patients with COVID-19 and 63 patients with CrKP were enrolled. A direct comparison between the two groups demonstrated more serious degrees of primary lung injury following 2019-nCoV infection (indicated by lower PaO
CONCLUSION:Critical COVID-19 shares clinical characteristics with classical bacterial sepsis, but the degree of systemic inflammatory response, secondary organ damage and mortality rate are less severe. However, following 2019-nCoV infection, the level of immunosuppression may be increased and thus induce in more death at the later stage of patients' hospitalstay.
